Rola wielonienasyconych kwasów tłuszczowych omega-3 w przebiegu zapaleń

• Autorzy: Kolanowski W.

Warianty tytułu

EN

Role of omega-3 polyunsaturated fatty acids in the course of inflammatio

• Języki publikacji: PL

Abstrakty

EN

Omega-3 polyunsaturated fatty acids, especially their long-chain form: eicosapentaenoic acid EPA and docosahexaenoic acid DHA have beneficial effects on animal and human health. Many studies indicate that the health promoting activity of these acids is to a large extent related to the regulation and resolving of the inflammatory process. Inflammation promotes many diseases, including arteriosclerosis, infections, autoimmune diseases, cancer, or neurodegenerative disorders. The beneficial health effects of omega-3 fatty acids results from the activity their metabolites, especially resolvins and protectins. The purpose of this paper was to present the mechanism of omega-3 fatty acids anti-inflammatory action.

Słowa kluczowe

PL

zapalenia; stany zapalne; kwasy tluszczowe wielonienasycone; kwasy tluszczowe omega-3; kwas eikozapentaenowy; kwas dokozaheksaenowy; dzialanie przeciwzapalne; przebieg zapalenia

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2015
• Tom: 71
• Numer: 10
• Opis fizyczny: s.608-614,rys.,tab.,bibliogr.

Twórcy

autor

Kolanowski W.

• Katedra Dietetyki i Oceny Żywności, Instytut Nauk o Zdrowiu, Uniwersytet Przyrodniczo-Humanistyczny w Siedlcach, ul. Konarskiego 2, 08-110 Siedlce

Bibliografia

• 1. Ariel A., Fredman G., Sun Y. P., Kantarci A., Van Dyke T. E., Luster A. D.: Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat. Immunol. 2006, 7, 1209-1216.
• 2. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N. A., Serhan C. N.: Stereochemical assignment, anti-inflammatory properties, and receptor. J. Exp. Med. 2005, 201, 713-722.
• 3. Arterburn L. M., Bailey Hall E., Oken H.: Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83, S1467-S1476.
• 4. Bang H., Dyerberg J.: Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med. Scand. 1972, 192, 85-94.
• 5. Calder P. C.: Polyunsaturated fatty acids and inflammation. Pros. Leuk. EFA 2006, 75, 197-202.
• 6. Das U. N.: Essential fatty acids: biochemistry, physiology and pathology. Biotechnol. J. 2006, 1, 420-439.
• 7. Flower R. J., Perretti M.: Controlling inflammation: a fat chance? J. Exp. Med. 2009, 201, 671-674.
• 8. Galli C., Calder P. C.: Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann. Nutr. Metab. 2009, 55, 123-139.
• 9. Goua M., Mulgrew S., Frank J., Rees D., Sneddon A. A., Wahle K.: Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: Involvement of the transcription factor NF-kB? Prostagl. Leukotr. Essent. Fatty Acids 2008, 78, 33-43.
• 10. Goyens P. L., Spilker M. E., Zock P. L., Katan M. B., Mensink R. P.: Compartmental modeling to quantify alpha-linolenic acid conversion after longer-term intake of multiple tracer boluses. J. Lipid Res. 2005, 46, 1474-1483.
• 11. Gronert K., Maheshwari N., Khan N., Hassan I. R., Dunn M., Laniado Schwartzman M.: A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 2005, 280, 15267-15278.
• 12. Karin M., Greten F. R.: NF-kappaB: linking inflammation and immunityto cancer development and progression. Nat. Rev. Immunol. 2005, 5, 749-759.
• 13. Kohli P., Levy B. D.: Resolvins and protectins: mediating solutions to inflammation. Br. J. Pharmacol. 2009, 158, 960-971.
• 14. Koistinaho M., Koistinaho J.: Interactions between Alzheimer’s disease and cerebral ischemia – focus on inflammation. Brain Res. Rev. 2005, 48, 240-250.
• 15. Kris-Etherton P. M., Hill A.: n-3 fatty acids: food or supplements? J. Am. Diet. Assoc. 2008, 108, 1125-1130.
• 16. Maderna P., Godson C.: Lipoxins: resolutionary road. Br. J. Pharmacol. 2009, 158, 947-959.
• 17. Massaro M., Scoditti E., Carluccio M. A., DeCaterina R.: Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostagl. Leukotr. Essent. Fatty Acids 2008, 79, 109-115.
• 18. Mori T., Burke V., Puddey I., Watts G., O’Neal D., Best J., Beilin L.: Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71, 1085-1094.
• 19. Pawlosky R. J., Hibbeln J. R., Novotny J. A., Salem N.: Physiological compartmental analysis of α-linolenic acid metabolism in adult humans. J. Lipid Res. 2001, 42, 1257-1265.
• 20. Poulsen R. C., Gotlinger K. H., Serhan C. N., Kruger M. C.: Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am. J. Hematol. 2008, 83, 437-445.
• 21. Ratnayake W., Galli C.: Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann. Nutr. Metab. 2009, 55, 8-43.
• 22. Schwab J. M., Chiang N., Arita M., Serhan C. N.: Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447, 869-874.
• 23. Seki H., Tani Y., Arita M.: Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostagl. Lipid Mediators 2009, 89, 126-130.
• 24. Serhan C. N.: Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8, 115-121.
• 25. Serhan C. N.: Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J. Thromb. Haemost. 2009, 7, S44-S48.
• 26. Serhan C. N., Yang R., Martinod K., Kasuga K., Pillai P., Porter T., Oh S., Spite M.: Maresins: novel macrophage mediators with potent anti inflamatory and proresolving actions. J. Exp. Med. 2008, 206, 15-23.
• 27. Simopoulos A. P.: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 2008, 233, 674-688.
• 28. Spite M., Summers L., Porter T. F., Srivastava S., Bhatnagar A., Serhan C. N.: Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br. J. Pharmacol. 2009, 158, 1062-1073.
• 29. Rutkowski R., Pancewicz S. A., Skrzydelska E., Hermanowska-Szpakowicz T.: Właściwości biologiczne czynnika transkrypcji jądrowej NF-κB. Alegria Astma Immunol. 2005, 10, 125-131.
• 30. Yedgar S., Krimsky M., Cohen Y., Flower R. J.: Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword? Trends Pharmacol. Sci. 2007, 28, 459-464.